iTeos Therapeutics
Latest round
- Series B
Last raised
- Mar 2020
Total raised
- $206M
Investors
- 16
About iTeos Therapeutics
, operates as a biopharmaceutical company that focuses on the development of immuno-oncology therapeutics for cancer patients.A. The company operates in locations like Watertown, Massachusetts, Gosselies, and Belgium. The company is listed on Nasdaq Stock exchange under ticker symbol, ITOS. iTeos Therapeutics offers various immunotherapy solutions by targeting immunometabolism and immunosuppressive cells in the tumour's microenvironment. The company’s pipelined products include Inupadenant, an A2A receptor antagonist, and EOS-448, used as a treatment for solid tumours in monotherapy and as an anti-TIGIT antibody antagonist in patients with cancer. In May 2024, iTeos Therapeutics Inc.50 per share.
Who invested in iTeos Therapeutics
16 investors across 4 rounds
See all investors in iTeos Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about iTeos Therapeutics
Who invested in iTeos Therapeutics?
iTeos Therapeutics has 16 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iTeos Therapeutics raised?
iTeos Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did iTeos Therapeutics last raise money?
iTeos Therapeutics's most recent round on record is a Series B, in Mar 2020.
What does iTeos Therapeutics do?
, operates as a biopharmaceutical company that focuses on the development of immuno-oncology therapeutics for cancer patients.
Where is iTeos Therapeutics headquartered?
iTeos Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like iTeos Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at iTeos Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like iTeos Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.